CLINICAL_TRIALS
trial_result
· 2019-06-03
Clinical Trial Update: A Study of LY2623091 in Male and Females With Chronic Kidney Disease [Phase 2]
Summary
Phase 2 clinical trial update for LY2623091 in adults with chronic kidney disease; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-06-03